{"id":61678,"date":"2025-08-02T01:05:43","date_gmt":"2025-08-01T23:05:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/"},"modified":"2025-08-02T01:05:43","modified_gmt":"2025-08-01T23:05:43","slug":"align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/","title":{"rendered":"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock"},"content":{"rendered":"
\n

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (\u201cAlign\u201d) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae<\/sup> System of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of Align\u2019s common stock. Since his last sale of Align common stock in 2021, Mr. Hogan has purchased approximately $8 million of Align common stock1<\/sup>.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cThis purchase reflects my continuing confidence in the long-term value of Align and our commitment to increasing shareholder value by balancing investments to drive growth and continuing to invest with discipline in the areas that will define our future,\u201d said Joe Hogan, president and CEO. \u201cWe are excited about our next-generation technologies and treatment platforms that meet today\u2019s patient expectations for fast, effective, and personalized treatment while also providing value and growth opportunities for our doctor customers. We believe that these innovations are not only improving outcomes in Invisalign practices but also expanding our addressable market and strengthening our competitive differentiation.\u201d<\/p>\n

\nContinued Hogan, \u201cWhile we believe that the macroeconomic uncertainty will likely persist into the near future, we are confident in our ability to adapt and lead. Our long-term strategic initiatives and opportunities remain intact, as does our commitment to focused execution on transforming treatment for doctors and patients.\u201d<\/p>\n

\n1<\/sup> Valued based on the purchase price of Align common stock at the time of each purchase.<\/p>\n

\nAbout Align Technology<\/span><\/b><\/p>\n

\nAlign Technology designs and manufactures the Invisalign\u00ae<\/sup> System, the most advanced clear aligner system in the world, iTero\u2122 intraoral scanners and services, and exocad\u2122 CAD\/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 286.4 thousand doctor customers and are key to accessing Align\u2019s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.8 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align\u2122 Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab\/partners. Visit www.aligntech.com<\/a> for more information.<\/p>\n

\nFor additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com<\/a>. For additional information about the iTero digital scanning system, please visit www.itero.com<\/a>. For additional information about exocad dental CAD\/CAM offerings and a list of exocad reseller partners, please visit www.exocad.comwww.exocad.com<\/a>.<\/p>\n

\nInvisalign, iTero, exocad, Align, Align Digital Platform, and iTero Lumina are trademarks of Align Technology, Inc.<\/p>\n

Contacts<\/b> <\/p>\n

\nAlign Technology, Inc.
\n
Madelyn Valente
\n
(909) 833-5839
\n
mvalente@aligntech.com<\/a><\/p>\n

\nZeno Group
\n
Sarah Karlson
\n
(828) 551-4201
\n
sarah.karlson@zenogroup.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (\u201cAlign\u201d) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae System of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61678","6":"format-standard","7":"category-industry"},"yoast_head":"\nAlign Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (\u201cAlign\u201d) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae System of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-01T23:05:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250801975263\/en\/1470772\/22\/Align_tagline_vertical_RGB_charcoal_2c.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock\",\"datePublished\":\"2025-08-01T23:05:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/\"},\"wordCount\":482,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250801975263\\\/en\\\/1470772\\\/22\\\/Align_tagline_vertical_RGB_charcoal_2c.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/\",\"name\":\"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250801975263\\\/en\\\/1470772\\\/22\\\/Align_tagline_vertical_RGB_charcoal_2c.jpg\",\"datePublished\":\"2025-08-01T23:05:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250801975263\\\/en\\\/1470772\\\/22\\\/Align_tagline_vertical_RGB_charcoal_2c.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250801975263\\\/en\\\/1470772\\\/22\\\/Align_tagline_vertical_RGB_charcoal_2c.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/","og_locale":"en_US","og_type":"article","og_title":"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock - Pharma Trend","og_description":"TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (\u201cAlign\u201d) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae System of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-01T23:05:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250801975263\/en\/1470772\/22\/Align_tagline_vertical_RGB_charcoal_2c.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock","datePublished":"2025-08-01T23:05:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/"},"wordCount":482,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250801975263\/en\/1470772\/22\/Align_tagline_vertical_RGB_charcoal_2c.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/","url":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/","name":"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250801975263\/en\/1470772\/22\/Align_tagline_vertical_RGB_charcoal_2c.jpg","datePublished":"2025-08-01T23:05:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250801975263\/en\/1470772\/22\/Align_tagline_vertical_RGB_charcoal_2c.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250801975263\/en\/1470772\/22\/Align_tagline_vertical_RGB_charcoal_2c.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/align-technology-president-and-ceo-joe-hogan-personally-purchases-1-million-of-aligns-common-stock\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align\u2019s Common Stock"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61678"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61678\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}